Position in GH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,277,199
-$5,837,771 QoQ
Shares Held
13,827
-80.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $144,650,872 across 23 Diagnostics & Research names. GH ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
239,432 | $46,923,883 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
22,818 | $28,778,061 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
|
1,233,951 | $19,619,820 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
33,998 | $19,103,136 | |
| 5 | CSTL |
Castle Biosciences Inc
|
484,441 | $11,893,026 | |
| 6 | MYGN |
Myriad Genetics Inc
|
2,308,589 | $10,388,650 | |
| 7 | XGN |
Exagen Inc.
|
689,114 | $2,067,342 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
13,827 | $1,277,199 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,277,199 | 13,827 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,114,970 | 69,659 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $30,552 | 489 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $251,628 | 10,969 | Shares | Defined | 2024-11-12 | |
| 2023-03-31 | $37,269 | 1,590 | Shares | Defined | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||